Scheer Partners Investments

What Scheer Partners Investments does

Scheer Partners is a privately held, founder-owned commercial real estate firm founded in 1991 and headquartered in Rockville, Maryland, operating across the Mid-Atlantic region through regional offices in Philadelphia, Research Triangle Park, and Charlotte. The firm offers eight integrated service lines: Agency Leasing, Scientific Brokerage & Advisory, Industrial Leasing & Sales, Healthcare & Office Leasing, Facility & Property Management, Project Development & Construction Management, Capital Markets, and Life Science Investments (operated through its South Duvall subsidiary). Its core competitive positioning centers on a specialized focus on scientific and biotech real estate, with a client roster spanning pre-revenue biotech start-ups to publicly traded pharmaceutical companies including Novavax, AstraZeneca, Regenxbio, Supernus, Arcellx, and Sirnaomics.

The firm operates on a diversified revenue model combining transactional brokerage commissions (for agency leasing, scientific brokerage, industrial leasing/sales, capital markets investment property dispositions), recurring managed services revenue (facility and property management), and project-based professional services fees (owner representation, design management, construction management). The Life Science Investments subsidiary extends the firm into principal balance-sheet investment in value-add and income-producing life science properties. Customers span four primary verticals: life sciences (its flagship segment), healthcare providers, industrial/business operations, and office tenants, with a separate investor customer segment served by the Capital Markets division targeting private equity, high net worth investors, 1031 exchange investors, and REITs.

Go-to-market is executed through a fully integrated in-house team of approximately 30-40 brokers and specialists distributed across regional offices, supported by thought-leadership content (market research reports, blog insights on trends such as "Flight to Efficiency" and "From Capacity to Capability") and direct enterprise field sales. Recent strategic emphasis has been on geographic expansion into the Carolinas and Southern New Jersey, deepening the development and construction management service line, and ecosystem-level engagements such as managing the $26 million RoVa Labs biotech incubator in Roanoke, Virginia in partnership with Carilion Clinic, Virginia Tech, and the Roanoke Blacksburg Innovation Alliance.

Name

Scheer Partners Investments

Legal name

Scheer Partner's Inc.

Website

https://scheerpartners.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

Scheer Partners is a privately held, founder-owned Mid-Atlantic commercial real estate firm founded in 1991, offering integrated brokerage, advisory, property management, and project development services with a specialized focus on scientific, biotech, healthcare, and industrial properties across the Mid-Atlantic and Carolinas.

Ownership category

akta.pro rank

Product category

Commercial Real Estate Services

NAICS

Offices of Real Estate Agents and Brokers (53121)

SIC

Real Estate Agents & Managers (For Others) (6531), Real Estate Dealers (For Their Own Account) (6532)

akta.pro primary industry

Special Purpose & Alternative Asset Brokerage (BPAJABAH)

akta.pro secondary industry

Hazardous Materials & Specialized Industrial Facilities Brokerage (BPAJACAI)

Keywords

• Commercial real estate services
• Commercial real estate brokerage
• Life science real estate
• Property management services
• Real estate investment sales

Headquarters

HQ city

Rockville

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Agency Leasing & Brokerage Commissions: Traditional real estate brokerage revenue generated from agency leasing representation for both landlords and tenants in commercial, industrial, healthcare, and life sciences properties.
2. Scientific Brokerage & Advisory Fees: Advisory service fees for developing real estate strategies and solutions for life science companies, including site selection, market research, and location strategy.
3. Facility & Property Management Services: Ongoing property and facility management services providing recurring revenue from tenant needs, facility operations, and financial management.
4. Project Development & Construction Management: Owner representation, design management, and construction management services for development projects.
5. Capital Markets - Investment Property Sales: Disposition services for suburban investment properties, targeting private equity, high net worth investors, 1031 exchange investors, and REITs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Scheer Partners Investments is a full-service commercial real estate firm offering integrated brokerage, advisory, property management, project development, and capital markets services across the Mid-Atlantic region. It specializes in scientific/biotech, healthcare, office, industrial, and retail properties, delivering tenant and landlord representation, site selection, facility planning, construction management, and investment property dispositions through an in-house team of experienced brokers. A dedicated life science investments arm (South Duvall) focuses on value-add and select income-producing properties.

Product overview

Scheer Partners is a full-service commercial real estate firm offering integrated real estate services across the Mid-Atlantic region. The company's service portfolio includes eight distinct offerings: Agency Leasing for property marketing and tenant acquisition; Scientific Brokerage & Advisory serving life science companies; Industrial Leasing & Sales for warehouse and distribution facilities; Healthcare & Office Leasing for medical and commercial office spaces; Facility & Property Management; Project Development & Construction Management; Capital Markets for investment property sales; and Life Science Investments. These services are delivered through a fully integrated, in-house team of experienced brokers serving scientific/biotech, office, healthcare, industrial, and retail property markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Agency Leasing Comprehensive agency leasing services to maximize commercial property value through property/market analysis, targeted marketing, tenant identification, negotiation, lease administration, and performance analysis for property owners.
• Scientific Brokerage & Advisory Specialized real estate solutions for life science companies including market research, development/acquisition, labor analytics, ecosystem building, location strategy, and economic incentives advisory services for biotech and pharmaceutical clients.
• Industrial Leasing & Sales Industrial and warehouse property leasing and sales services, including tenant/landlord representation and buyer/seller representation for acquisition of distribution facilities across the Mid-Atlantic.
• Healthcare & Office Leasing Medical and office leasing services providing tenant representation for solo practitioners to multi-location practices, including practice requirement analysis, patient demographic evaluation, site selection, and lease negotiations.
• Facility & Property Management Comprehensive facility and property management services including facility operations, client/owner relations, financial management, engineering, operations logistics, and sustainability compliance for managed properties.
• Project Development & Construction Management Owner representation, design management, and construction management services for projects from acquisition due diligence through ground-up development, building conversion, and tenant fitout.
• Capital Markets Dispositions of suburban investment properties throughout the Mid-Atlantic region, targeting private equity, high net worth investors, 1031 exchange investors, and REITs.
• Life Science Investments Investment focus on value-add properties and select income-producing properties in the life science sector, operated through the South Duvall subsidiary.

Quantifiable outcome

• Supported growth of hundreds of scientific companies from pre-revenue start-ups to Fortune 500 leaders
• +1 more outcomes

Named customers14 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• RoVa Labs (Roanoke Valley Life Sciences)notableStrategic or Co-development Partner · 7 May 2026Scheer Partners manages the RoVa Labs biotech incubator, a $26 million collaborative project in Roanoke, Virginia. The 40,000-square-foot facility is a joint initiative involving Carilion Clinic, Virginia Tech, and the Roanoke Blacksburg Innovation Alliance. The incubator is projected to create 250 jobs within five years while supporting early-stage life sciences companies.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• NAI Global: Global network of independently owned commercial real estate firms. Comparable mid-market CRE brokerage model with similar service breadth (leasing, investment sales, property management) and owner-operated culture.
• T3 Advisors: Boutique commercial real estate firm specializing in life science and technology real estate. Most directly comparable niche peer to Scheer Partners' scientific brokerage practice, serving similar biotech, pharma, and tech tenants.
• Lee & Associates: Privately held, principal-owned commercial real estate brokerage firm with multiple offices. Closely comparable mid-size, founder-influenced CRE firm competing in industrial, office, and investment sales across similar geographies.

Broad incumbents

• Avison Young: Privately held global CRE services firm competing in agency leasing, capital markets, and project management. Has a Life Sciences practice and Mid-Atlantic presence that overlaps with Scheer Partners.
• JLL (Jones Lang LaSalle): Global CRE services firm with an established Life Sciences specialty group. Competes directly with Scheer Partners in scientific brokerage, project development, and capital markets for life science clients across the Mid-Atlantic.
• Cushman & Wakefield: Global CRE services firm competing across agency leasing, valuation, and capital markets. Has an Americas Life Sciences practice that competes for the same biotech and pharma tenants as Scheer Partners.
• Transwestern: Privately held national CRE services firm with agency leasing, tenant representation, and capital markets capabilities. Competes with Scheer Partners for office, healthcare, and life science tenants in major Mid-Atlantic submarkets.
• Colliers International: Global CRE services and investment management firm with a Project Leaders / Life Sciences practice. Competes with Scheer Partners in agency leasing, project management, and healthcare/life science real estate in the Mid-Atlantic.
• Newmark Group: Full-service CRE services firm with growing life sciences capabilities. Direct competitor in Mid-Atlantic industrial and investment sales, and a known prior employer of multiple Scheer Partners hires (Bradford Mills, Jack Gitlin).
• CBRE Group: Global commercial real estate services giant with a dedicated Life Sciences practice. Competes with Scheer Partners across agency leasing, capital markets, and project management, but operates at vastly greater scale and geographic breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/scheer-partners
• Xx.com/scheerpartners
• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scheer Partners Investments